Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancerJulia Foldi, Lajos Pusztai|npj Breast Cancer|2021Cited by 67
RBP-J is required for M2 macrophage polarization in response to chitin and mediates expression of a subset of M2 genesJulia Foldi, Xiaoyu Hu|Protein & Cell|2016Cited by 57
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancerLuca Licata, Giampaolo Bianchini, Lucia Del Mastro et al.|npj Breast Cancer|2023Cited by 18
187P Impact of oncotype DX on agreement and confidence in adjuvant treatment decision making in breast cancerLuca Licata, Giampaolo Bianchini, Giulia Viale et al.|Annals of Oncology|2020Cited by 0